2,835
Views
52
CrossRef citations to date
0
Altmetric
Research Article

Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer

, , , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 654-667 | Received 26 Dec 2017, Accepted 11 Feb 2018, Published online: 01 Mar 2018

References

  • Adachi M, Hinatsu Y, Kusamori K, et al. (2015). Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers. Eur J Pharm Sci 76:225–30.
  • Akram M, Iqbal M, Daniyal M, Khan AU. (2017). Awareness and current knowledge of breast cancer. Biol Res 50:33.
  • Allahham A, Stewart P, Marriott J, Mainwaring DE. (2004). Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer. Int J Pharm 270:139–48.
  • Andreani T, Miziara L, Lorenzon EN, et al. (2015). Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models. Eur J Pharm Biopharm 93:118–26.
  • Benson JR, Jatoi I, Toi M. (2016). Treatment of low-risk ductal carcinoma in situ: is nothing better than something? Lancet Oncol 17:e442–51.
  • Biruss B, Valenta C. (2008). The advantage of polymer addition to a non-ionic oil in water microemulsion for the dermal delivery of progesterone. Int J Pharm 349:269–73.
  • Carvalho VF, De Lemos DP, Vieira CS, et al. (2017a). Potential of non-aqueous microemulsions to improve the delivery of lipophilic drugs to the skin. AAPS PharmSciTech 18:1739–49.
  • Carvalho VFM, Migotto A, Giacone DV, et al. (2017b). Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models. Eur J Pharm Sci 109:131–43.
  • Chou TC. (2010). Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440–6.
  • Chun YS, Bisht S, Chenna V, et al. (2012). Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis 33:2242–9.
  • Cichewicz A, Pacleb C, Connors A, et al. (2013). Cutaneous delivery of alpha-tocopherol and lipoic acid using microemulsions: influence of composition and charge. J Pharm Pharmacol 65:817–26.
  • Contri RV, Fiel LA, Alnasif N, et al. (2016). Skin penetration and dermal tolerability of acrylic nanocapsules: influence of the surface charge and a chitosan gel used as vehicle. Int J Pharm 507:12–20.
  • Da Silva SB, Ferreira D, Pintado M, Sarmento B. (2016). Chitosan-based nanoparticles for rosmarinic acid ocular delivery–In vitro tests. Int J Biol Macromol 84:112–20.
  • Desai A, Vyas T, Amiji M. (2008). Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations. J Pharm Sci 97:2745–56.
  • Eichenbaum G, Zhou J, De Smedt A, et al. (2013). Methods to evaluate and improve the injection site tolerability of intravenous formulations prior to first-in-human testing. J Pharmacol Toxicol Methods 68:394–406.
  • Fangueiro JF, Calpena AC, Clares B, et al. (2016). Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): in vivo, in vitro and ex vivo studies. Int J Pharm 502:161–9.
  • Francis A, Fallowfield L, Rea D. (2015a). The LORIS trial: addressing overtreatment of ductal carcinoma in situ. Clin Oncol (R Coll Radiol) 27:6–8.
  • Francis A, Thomas J, Fallowfield L, et al. (2015b). Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51:2296–303.
  • Fu H, Shi K, Hu G, et al. (2015). Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol). J Pharm Sci 104:1160–73.
  • Ganem-Quintanar A, Quintanar-Guerrero D, Buri P. (2000). Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm 26:809–20.
  • Groen EJ, Elshof LE, Visser LL, et al. (2017). Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). Breast 31:274–83.
  • Heidor R, Ortega JF, De Conti A, et al. (2012). Anticarcinogenic actions of tributyrin, a butyric acid prodrug. Curr Drug Targets 13:1720–9.
  • Hoeller S, Sperger A, Valenta C. (2009). Lecithin based nanoemulsions: a comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. Int J Pharm 370:181–6.
  • Hosmer JM, Steiner AA, Lopes LB. (2013). Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride. Pharm Res 30:694–706.
  • INVITTOX Protocol n. 96 Hen’s egg test on the chorioallanthoic membrane (HET-CAM). Available at: https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/protocol/hen’s-egg-test-on-the-chorioallantoic-membrane-(het-cam)-protocol-no.-96/key/p_684
  • Kang SN, Hong SS, Lee MK, Lim SJ. (2012). Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib. Int J Pharm 428:76–81.
  • Krahn CL, Raffin RP, Santos GS, et al. (2012). Isoflurane-loaded nanoemulsion prepared by high-pressure homogenization: investigation of stability and dose reduction in general anesthesia. J Biomed Nanotechnol 8:849–58.
  • Krause S, Brock A, Ingber DE. (2013). Intraductal injection for localized drug delivery to the mouse mammary gland. J Vis Exp 80:50692.
  • Lopes LB, Murphy N, Nornoo A. (2009). Enhancement of transdermal delivery of progesterone using medium-chain mono and diglycerides as skin penetration enhancers. Pharm Dev Technol 14:524–9.
  • Lopez-Marure R, Gutierrez G, Mendoza C, et al. (2002). Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis. Biochem Biophys Res Commun 293:1028–36.
  • Love S, Zhang B, Zhang W, et al. (2009). Local drug delivery to the breast: a phase 1 study of breast cytotoxic agent administration prior to mastectomy. BMC Proc 5:S29.
  • Maguire R, Duggan O, Kavanagh K. (2016). Evaluation of Galleria mellonella larvae as an in vivo model for assessing the relative toxicity of food preservative agents. Cell Biol Toxicol 32:209–16.
  • Mahoney ME, Gordon EJ, Rao JY, et al. (2013). Intraductal therapy of ductal carcinoma in situ: a presurgery study. Clin Breast Cancer 13:280–6.
  • Masso-Welch PA, Darcy KM, Stangle-Castor NC, Ip MM. (2000). A developmental atlas of rat mammary gland histology. J Mammary Gland Biol Neoplasia 5:165–85.
  • Mazzarino L, Travelet C, Ortega-Murillo S, et al. (2012). Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J Colloid Interface Sci 370:58–66.
  • Mckenzie B, Kay G, Matthews KH, et al. (2015). The hen's egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: quantification using Photoshop(R) and ImageJ. Int J Pharm 490:1–8.
  • Megaw J, Thompson TP, Lafferty RA, Gilmore BF. (2015). Galleria mellonella as a novel in vivo model for assessment of the toxicity of 1-alkyl-3-methylimidazolium chloride ionic liquids. Chemosphere 139:197–201.
  • Mehling A, Kleber M, Hensen H. (2007). Comparative studies on the ocular and dermal irritation potential of surfactants. Food Chem Toxicol 45:747–58.
  • Mukhopadhyay P, Chakraborty S, Ponnusamy MP, et al. (2011). Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochim Biophys Acta 1815:224–40.
  • Murata S, Kominsky SL, Vali M, et al. (2006). Ductal access for prevention and therapy of mammary tumors. Cancer Res 66:638–45.
  • Narod SA, Iqbal J, Giannakeas V, et al. (2015). Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1:888–96.
  • Naz S, Shahzad H, Ali A, Zia M. (2017). Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment. Artif Cells Nanomed Biotechnol. DOI:10.1080/21691401.2017.1375937
  • Ng WY, Migotto A, Ferreira TS, Lopes LB. (2017). Monoolein-alginate beads as a platform to promote adenosine cutaneous localization and wound healing. Int J Biol Macromol 102:1104–11.
  • Nornoo AO, Zheng H, Lopes LB, et al. (2009). Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies. Eur J Pharm Biopharm 71:310–17.
  • Nybond S, Bjorkqvist YJ, Ramstedt B, Slotte JP. (2005). Acyl chain length affects ceramide action on sterol/sphingomyelin-rich domains. Biochim Biophys Acta 1718:61–6.
  • Olshefski RS, Ladisch S. (2001). Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity. Int J Cancer 93:131–8.
  • Pepe D, Carvalho VF, Mccall M, et al. (2016). Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel. Int J Nanomedicine 11:2009–19.
  • Pepe D, Mccall M, Zheng H, Lopes LB. (2013). Protein transduction domain-containing microemulsions as cutaneous delivery systems for an anticancer agent. J Pharm Sci 102:1476–87.
  • Pepe D, Phelps J, Lewis K, et al. (2012). Decylglucoside-based microemulsions for cutaneous localization of lycopene and ascorbic acid. Int J Pharm 434:420–8.
  • Phelps J, Bentley MV, Lopes LB. (2011). In situ gelling hexagonal phases for sustained release of an anti-addiction drug. Colloids Surf B Biointerfaces 87:391–8.
  • Rozman B, Zvonar A, Falson F, Gasperlin M. (2009). Temperature-sensitive microemulsion gel: an effective topical delivery system for simultaneous delivery of vitamins C and E. AAPS PharmSciTech 10:54–61.
  • Sagara Y, Mallory MA, Wong S, et al. (2015). Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg 150:739–45.
  • Selzner M, Bielawska A, Morse MA, et al. (2001). Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61:1233–40.
  • Senchenkov A, Han TY, Wang H, et al. (2001). Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT(388)-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF. Blood 98:1927–34.
  • Shen Z, Shen T, Wientjes MG, et al. (2008). Intravesical treatments of bladder cancer: review. Pharm Res 25:1500–10.
  • Singh Y, Gao D, Gu Z, et al. (2012). Influence of molecular size on the retention of polymeric nanocarrier diagnostic agents in breast ducts. Pharm Res 29:2377–88.
  • Stover T, Kester M. (2003). Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 307:468–75.
  • Stover TC, Sharma A, Robertson GP, Kester M. (2005). Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 11:3465–74.
  • Struckhoff AP, Bittman R, Burow ME, et al. (2004). Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. J Pharmacol Exp Ther 309:523–32.
  • Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. (2013). Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm 443:293–305.
  • Thomas S, Vieira CS, Hass MA, Lopes LB. (2014). Stability, cutaneous delivery, and antioxidant potential of a lipoic acid and alpha-tocopherol codrug incorporated in microemulsions. J Pharm Sci 103:2530–8.
  • Torcello-Gómez A, Wulff-Pérez M, Gálvez-Ruiz MJ, et al. (2014). Block copolymers at interfaces: Interactions with physiological media. Adv Colloid Interface Sci 206:414–27.
  • Valenta C, Schultz K. (2004). Influence of carrageenan on the rheology and skin permeation of microemulsion formulations. J Control Release 95:257–65.
  • Ward EM, Desantis CE, Lin CC, et al. (2015). Cancer statistics: breast cancer in situ. CA Cancer J Clin 65:481–95.
  • Xiao W, Suby N, Xiao K, et al. (2017). Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer. J Control Release 264:169–79.
  • Zhang B, Love SM, Chen G, et al. (2014). The safety parameters of the study on intraductal cytotoxic agent delivery to the breast before mastectomy. Chin J Cancer Res 26:579–87.
  • Zhang X, Yi Y, Qi J, et al. (2013). Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs. Int J Pharm 452:233–40.